Contrast-enhanced harmonic endoscopic ultrasound for pancreatic mass lesions

Contrast-enhanced harmonic endoscopic ultrasound for pancreatic mass lesions - Contrast EUS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34952

Enrollment

Registered

2010-06-29

Start date

2010-07-12

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas "mass"

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Adult patient 18 years or older. 2) Able to read & write in Dutch. 3) Undergoing EUS for the evaluation of a solid pancreatic lesion.

Exclusion criteria

Exclusion criteria: 1) Cystic pancreatic lesion. 2) Known allergy to Sonovue (contrast agent). 3) Unstable ischemic heart disease (contra-indication to Sonovue).

Design outcomes

Primary

Measure	Time frame
Descriptions of the contrast-enhanced vascular perfusion patterns of solid pancreatic mass lesions, and the correlations to the histological diagnoses obtained from FNA or subsequent surgery. This will enable derivation of the sensitivity, specificity, positive predictive value and negative predictive value of each contrast harmonic EUS image pattern for the different solid lesions in the pancreas.	—

Measure

Time frame

Descriptions of the contrast-enhanced vascular perfusion patterns of solid pancreatic mass lesions, and the correlations to the histological diagnoses obtained from FNA or subsequent surgery. This will enable derivation of the sensitivity, specificity, positive predictive value and negative predictive value of each contrast harmonic EUS image pattern for the different solid lesions in the pancreas.

—

Countries

Netherlands

Outcome results